Immuron (IMRN) EBIT (2016 - 2024)
Immuron (IMRN) recorded quarterly EBIT of $1660259127.7 billion in Q4 2024, up 82189906661311.72% quarter-over-quarter from -$2.0 million in Q4 2023, and up 82189906661311.72% on a YoY basis from N/an in Q1 2024.
Immuron (IMRN) EBIT (2016 - 2024) Analysis & Trends
Immuron's EBIT history runs 9 years deep, the most recent figure standing at $1660259127.7 billion for Q4 2024.
- In Q4 2024, EBIT rose 82189906661311.72% year-over-year to $1660259127.7 billion; the TTM figure through Dec 2024 stood at $1660259127.7 billion (up 12455400799.98% YoY), while the FY2025 annual figure was -$3.5 million, up 8.95% from the prior year.
- EBIT was $1660259127.7 billion for Q4 2024 at Immuron, up from -$2.0 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $1660259127.7 billion in Q4 2024 to a low of -$13.3 billion in Q4 2021.
- Historically, EBIT has averaged $276709852.4 billion across 5 years, with a median of -$648609.5 in 2023.
- The sharpest annual moves came in 2021 and 2024: EBIT sank 23228043.34% in 2021, then jumped 82189906661311.72% in 2024.
- A 5-year view of EBIT shows it stood at -$57371.6 in 2020, then tumbled by 23228043.34% to -$13.3 billion in 2021, then soared by 100.0% to -$12721.4 in 2022, then sank by 15779.01% to -$2.0 million in 2023, then surged by 82189906661311.72% to $1660259127.7 billion in 2024.
- The last three EBIT figures came in at $1660259127.7 billion (Q4 2024), -$2.0 million (Q4 2023), and -$1.2 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,660,259,127.73 Bn |
| Dec 31, 2023 | -2.02 Mn |
| Jun 30, 2023 | -1.24 Mn |
| Dec 31, 2022 | -12,721.37 |
| Dec 31, 2021 | -13.33 Bn |
| Dec 31, 2020 | -57,371.61 |
| Dec 31, 2019 | -15,191.40 |
| Dec 31, 2018 | -1.58 Mn |
| Dec 31, 2017 | 3.84 Mn |
| Dec 31, 2016 | 2.56 Mn |
| Jun 30, 2016 | 4.33 Mn |